Loading patent…
AssigneeOleg Iliich Epshtein
InventorsOleg Iliich Epshtein, Andrey Valerievich Strygin
Estimating the term…
The invention provides a combination pharmaceutical composition comprising a) at least one activated-potentiated form of an antibody to at least one cytokine or at least an activated-potentiated form of an antibody to at least one receptor; and b) an effective amount of a nucleoside reverse transcriptase inhibitor, wherein said at least one cytokine or at least one receptor is participating in the regulation of immune process. Various embodiments and variants are contemplated. The invention also provides a method of treatment or prophylaxis of HIV, including AIDS, which includes administration of the combination pharmaceutical composition described in the specification to the patient in need thereof.
A combination pharmaceutical composition comprising a) an activated-potentiated form of an antibody to at least one cytokine and/or an activated-potentiated form of an antibody to at least one receptor;
The combination pharmaceutical composition, wherein said nucleoside reverse transcriptase inhibitor is azidothymidine.
The pharmaceutical composition of claim 22, wherein said solid oral dosage form is a tablet.
Dependencies are inferred from the claim text.